MicroRNA-181 in cardiovascular disease: Emerging biomarkers and therapeutic targets

Area of Science:

• Biochemistry
• Molecular Biology
• Cardiology

Background:

• Cardiovascular disease (CVD) remains the primary global cause of mortality.
• MicroRNAs (MiRNAs) are increasingly recognized for their involvement in cardiovascular physiology and pathology.
• The microRNA-181 (miR-181) family has emerged as a significant focus in cardiovascular research.

Purpose of the Study:

• To review the transcription and regulation of miR-181.
• To summarize current knowledge on the roles of miR-181 family members in cardiovascular conditions.
• To explore the potential of miR-181 as biomarkers and therapeutic targets for CVD.

Main Methods:

• Literature review of recent findings on miR-181.
• Analysis of miR-181's role in atherosclerosis, myocardial infarction, hypertension, and heart failure.
• Examination of miR-181 transcription and regulatory mechanisms.

Main Results:

• miR-181 family members are implicated in various cardiovascular disease states.
• These miRNAs show potential as diagnostic biomarkers for CVD.
• miR-181 modulation presents possible therapeutic strategies for cardiovascular conditions.

Conclusions:

• Understanding miR-181's function offers new insights into CVD.
• miR-181 represents a promising avenue for future CVD research and treatment.
• Targeting miR-181 may lead to novel interventions for cardiovascular diseases.